Bristol-Myers Squibb (BMY) Earnings Date & Reports

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

BMY is expected to report earnings to fall 6.67% to $1.68 per share on July 31

Bristol-Myers Squibb BMY Stock Earnings Reports

Q2'25

Est.

$1.68

Q1'25

Beat

by $0.28

Q4'24

Beat

by $0.20

Q3'24

Beat

by $0.30

Q2'24

Beat

by $0.43

The last earnings report on April 24 showed earnings per share of $1.80, beating the estimate of $1.52. With 5.52M shares outstanding, the current market capitalization sits at 109.66B.

View a ticker or compare two or three

Compare

BMY